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Abstract:  A new 12-membered macrolide, balticolid (1)  was isolated from the EtOAc 
extract  of  the  culture  broth  of  fungal  strain  222  belonging  to  the  Ascomycota,  which  
was  found  on  driftwood  collected  from  the  coast  of  the  Greifswalder  Bodden,  
Baltic  Sea,  Germany.  The  structure  of  balticolid  was  determined  to  be  (3R,11R),  
(4E,8E)-3-hydroxy-11-methyloxacyclododeca-4,8-diene-1,7-dione using extensive spectral 
data as well as the modified Mosher ester method. Balticolid (1) displayed anti-HSV-1 
activity with an IC50 value of 0.45 µM. 
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1. Introduction 
Marine  microorganisms  are  recognized  as  important  sources  of  pharmacologically  active 
metabolites [1–3]. In particular, a growing number of marine-derived fungi have been reported to 
produce novel bioactive secondary metabolites. In an earlier part of this chemical investigation we 
described the isolation and structure elucidation of several new antiviral naphthalenone derivatives 
from the EtOAc extract of an ascomycetous fungus [4].
 On further investigation of this fungus, we 
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describe  herein  the  isolation,  structure  elucidation  and  the  biological  activity  of  the  novel  
12-membered macrolide, balticolid (1). 
Fungal  metabolites  that  contain  twelve-membered  lactone  rings  like  recifeiolide  from 
Cephalosporium  recifei  [5],  cladospolides  A-C  from  Cladosporium  cladosporioides  [6]  and 
Cladosporium tenuissimum [7], patulolides A-C from Penicillium urticae [8,9], pandangolides 1–4 from 
Cladosporium herbarum [10] and chloriolide from Chloridium virescens var. chlamydosporum [11] have 
already been reported. 
2. Results and Discussion 
Balticolid (1) was obtained as colorless oil. Its molecular formula was determined to be C12H16O4 
by ESIMS at m/z 225 [M + H]
+ and by HRESIMS at m/z 471.2001 for C24H32O8Na as [2M + Na]
+, 
suggesting the existence of five degrees of unsaturation. The UV spectrum showed absorption bands 
consistent with a conjugated carbonyl group. Inspection
 of the 
1H and 
13C NMR data (Table 1) together 
with  DEPT  and  HMQC  spectral  data  revealed  the  presence  of  one  methyl,  three  methylenes,  six 
methines (four olefinic) and two quaternary carbons (carbonylic). 
In  addition,  the  IR  spectrum  showed  the  presence  of  a  hydroxyl  group  (3435  cm
−1)  and  trans 
disubstituted  alkenes  (1662  cm
−1).  An  absorption  band  appeared  at  1716  cm
−1,  and  is  due  to  the 
conjugated  ketone,  the  absorption  band  of  the  12-membered  lactone  potentially  merged  with  the 
aforementioned as a single absorption band. The 
1H NMR splitting pattern of 1 showed coupling 
between the protons at δH 1.34 and 5.11 which indicates the presence of a CH3-CH-O group. The  
1H-
1H COSY and ROESY spectra revealed two structural elements, one of C-2 to C-6 and the second 
from the unsaturated methine carbon C-8 to methyl group C-12. HMBC correlations observed from 
methylene protons H2-2 (δH 2.68, 2.62) and deshielded oxymethine proton H-11(δH 5.11) to carboxy 
carbon C-1 established the location of the ester linkage (Table 1). The HMBC correlation of H-3  
(δH 4.54) with C-1, C-2 together with molecular formula C12H16O4 indicated the presence of a methine 
group and a hydroxyl group at C-3. The presence of a methyl group at C-11 was deduced by the 
HMBC correlation of H3-12 (δH 1.34) with C-9 (δC 148.1), C-10 (δC 39.6) and C-11 (δC 72.1). The 
geometries of C4-C5 and C8-C9 double bonds were assigned E, E on the basis of 
1H-
1H coupling 
constants (JH4-H5 = 15.9 Hz, JH8-H9 = 16.1 Hz respectively) leading to the gross structure of 1 as shown 
(Figure 1). Therefore, compound 1 was established as (4E,8E)-3-hydroxy-11-methyloxacyclododeca-
4,8-diene-1,7-dione and named as balticolid. 
The orientation of hydroxyl group at C-3 (δH 69.1) was assigned by taking into account the 
1H-
1H 
coupling  constant  values  of  H-3  (δH  1.34)  with  all  the  neighboring  protons  (JH2a-H3  =  3.4  Hz,  
JH2b-H3 = 4.7 Hz, JH3-H4 = 2.8 Hz). On the basis of vicinal coupling constant values for other protons a 
3D structure for 1 was constructed as shown in Figure 2. These findings were also supported by cross 
peaks in ROESY spectrum and difference NOEs experiments.  
Furthermore, the absolute configuration of balticolid (1) at C-3 was deduced by modified high-field 
1H NMR Mosher method [12–14]. In order to determine the absolute configuration at C-3, balticolid 
(1) was treated with (R) and (S)-α-methoxy-α-trifluoromethyl-phenylacetyl chloride (MTPA-Cl) in the 
presence  of  4-dimethylaminopyridine  (DMAP)  and  dicyclohexylcarbodiimide  to  give  the  (S)-and  
(R)-MTPA esters respectively. In the 
1H NMR spectrum of the (S)-MTPA ester, the proton signals Mar. Drugs 2011, 9                     
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assigned to H-2a, and H-2b were observed at a higher field than those of the (R)-MTPA ester, and H-4, 
H-5, H-6a and H-6b were observed at a lower field than those of the (R)-MTPA ester. The bulk effect 
on  chemical  shifts  induced  by  esterification  with  the  chiral  reagents  was  calculated  using  
Δδ = (δS − δR), where δS and δR are the shifts (in ppm) of diagnostic protons neighboring the chiral 
center in balticolid (1) of the (S) and (R) Mosher’s esters respectively. The absolute configuration of 1 
was obtained by positioning the protons with positive Δδ values on the right side and those with 
negative Δδ values on the left side in the model described by Ohtani et al. [13] which clearly showed 
that the absolute configuration at C-3 was R (Figure 3).  
The relative configuration of 1 at C-11 was elucidated from the interactions observed in difference 
NOEs  experiments.  By  applying  a  decoupling  field  to  methine  proton  H-8  (δH  5.99)  there  was 
enhancement of H-5 (δH 5.75), H-6a (δH 3.43) and H-10a (δH 2.52) indicating that these protons are 
situated on the same face while H-6b is on the opposite face. Furthermore, enhancement of proton H-4  
(δH 5.73) and H-11 (δH 5.11) upon irradiation of H-2b (δH 2.68) and H-9 (δH 6.78) were observed 
respectively (Figure 2) indicating that these protons are situated on the opposite face or β-oriented in 1. 
Therefore, the absolute configurations of both chiral centers of 1 were assigned as 3R, 11R. 
Table  1. 
1H [CD3OD, 600 MHz] and 
13C NMR [CD3OD, 150 MHz] spectral data for 
compound 1
a. 
Position  δH
b  
1H-
1H COSY  ROESY  δC
c  HMBC (H→C)  
1  -  -  -  172.0 (s)  - 
2  2.62 (1H, dd, 13.4, 3.4 Ha)   2b, 3  - 
43.3 (t) 
1, 3, 4 
2.68 (1H, dd, 13.4, 4.7 Hb)  2a, 3  5/4, 11   1, 3, 4, 5 
3  4.54 (1H, m)   4, 2a/b (6a)  6a/6b  69.1(d)  1, 2 
4  5.73 (1H, dd, 15.9, 2.8)  5, 3  9, 2a/2b   138.4 (d)  3, 5, 6 
5  5.75 (1H, m)  4, 6a/b  2a/2b   125.2 (d)  3, 4, 6, 7 
6 
 
3.43 (1H, br dd, 13.6, 6.8, Ha)  6b, 5, 3  8 
45.8 (t) 
4, 5, 7, 8   
3.22 (1H, ddd 13.6, 4.5, 1.7, Hb)   6a, 5   9, 3  4, 5, 7   
7  -  -  -  202.7 (s)  - 
8  5.99 (1H, br d, 16.1)  9, 10a/b  10a/10b  132.8 (d)  6, 7, 9, 10, 11 
9  6.78 (1H, ddd, 16.1, 8.9, 6.6)   8, 10a/b  6b/6a, 5/4, 11, 10b/10a  148.1 (d)  8, 10, 11  
10  2.52 (1H, dddd, 13.4, 6.6, 3.3, 1.3, Ha)  10b, 9, 11 (8)  8, 11  
39.6 (t) 
8, 9, 11 
2.38 (1H, ddd, 13.4, 11.0, 8.9, Hb)   10a, 9, 11, (8)  8, 11   8, 9, 11, 12 
11  5.11 (1H, ddq, 11.0, 3.3, 6.3)  10a/b, 12  10b/10a, 9  72.1 (d)  1, 9, 10, 12 
12  1.34 (3H, d, 6.3)  11  10b/10a, 2b/2a   21.1 (q)  9, 10, 11 
a All assignments are based on 1D and 2D measurements (DEPT, COSY, ROESY, HMQC, HMBC). 
b Chemical shifts ( δ ) were expressed in ppm, J in Hz. 
c Implied multiplicities were determined by DEPT (C = s, CH = d, CH2 = t). 
Compound 1 was tested at non-cytotoxic concentrations for antiviral activity against influenza A 
virus and Herpes simplex virus (HSV) type I. Balticolid was only found to exhibit inhibitory activity 
against herpes simplex virus with an IC50 value of 0.45 µM compared to 0.44 µM/aciclovir. The 
compound showed no remarkable antimicrobial activity against Staphylococcus aureus, Escherichia 
coli, and Candida maltosa at 200 µg/disc in the agar-diffusion assay. Further structural modifications 
to optimize physico-chemical properties, by total and semi-synthetic approach could result in more Mar. Drugs 2011, 9                     
 
 
847 
potent molecules with desirable pharmacokinetic properties. Thorough structure activity relationship 
(SAR)  studies  of  balticolid  derivatives  might  result  in  new  drug-lead  candidates  which  can  be 
exploited as future drugs.  
Figure 1. Structure of balticolid (1). 
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Figure  2.  Key  NOEs  observed  for  balticolid  (1),  and  their  corresponding  interatomic 
distances (Å). 
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Figure 3. Key 
1H NMR chemical shift differences Δδ (δS − δR) in ppm for the MTPA esters of 1. 
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3. Experimental Section 
3.1. General Experimental Procedures 
TLC: silica gel 60 F254 on aluminum foil (Merck); detection under daylight and UV light ( = 254 
and 366 nm), and anisaldehyde (1% in a solution of 10 mL of AcOH in 10 mL of a 15% methanolic 
H2SO4).  Column  Chromatography  (CC):  System  1:  silica  gel  (0.063–0.200  µm),  solvent  gradient: 
EtOAc/hexane/MeOH 65:35:5, EtOAc/MeOH 95:5, EtOAc/MeOH 50:50, and MeOH. System 2: silica 
gel (0.015–0.040 µm), solvent gradient: DCM/EtOAc 75:25, and EtOAc. RP-HPLC: 250 ×  4 mm; 
Waters Xterra-RP-C18, 5 µm, gradient 10% MeOH to 100% MeOH in 15 min, 1.0 mL/min. Optical 
rotation and UV spectra were measured in UV MeOH [Uvasol (Merck)] on a Polarimeter MC 241 
(Perkin  Elmer)  and  a  UV-2102  PC  UV-VIS  scanning  spectrophotometer,  respectively  in  nm  λmax 
(logε). IR spectra were measured on a Nicolet 20 DXB FT-IR spectrometer. For NMR spectroscopy 
the samples were dissolved in 99.95% CD3OD. NMR spectra were recorded at 300 K on Bruker 
DPX300, DMX600 NMR spectrometers locked to the major resonance of CD3OD. Chemical shifts are 
given relative to the residual solvent signal, CD3OD (
1H: 3.31 ppm; 
13C: 49.15 ppm), δ in ppm, J in 
Hz. MS: HPLC/MS: 1200 Series HPLC system (Agilent) coupled to a DAD-UV detector (Agilent) and 
an  API  2000  (Sciex);  in  m/z  (rel.%);  HR-MS:  with  an  ultra-performance  LC  system  (Accela;  
Thermo-Fisher, Germany) coupled via automated chip-based nanoelectrospray (NanoMate; Advion, 
UK) to the LTQ-Orbitrap mass spectrometer (Thermo-Fisher). 
3.2. Strain and Fermentation 
The  strain  222  was  isolated  from  driftwood  collected  in  November  2002  from  the  coast  of 
Greifswalder  Bodden,  Baltic  Sea,  Germany,  by  G.  Mernitz  and  B.  Cuypers.  The  material  was 
classified  by  A.  W.  A.  M.  de  Cock,  Centraalbureau  voor  Schimmelcultures,  Fungal  Biodiversity 
Centre, Utrecht, The Netherlands, and M. Unterseher, University Greifswald, Institute for Botany and 
Landscape Ecology, Greifswald, Germany, as a member of the order Pleosporales, Ascomycota, by 
ITS sequence (accession number in the European Nucleotide Archive FR852578). Since the isolate 
remained sterile in subcultures on different media an exact taxonomic determination was not possible. 
The culture has been deposited in the culture collection of the Department of Pharmaceutical Biology, 
University  of  Greifswald  (Voucher  number  222).  Fermentation  was  carried  out  in  liquid  shake 
cultures. 500 mL Erlenmeyer flasks  containing 200 mL of Hagem medium (ammonium succinate  
0.5 g; KH2PO4 0.5 g; MgSO4 7H2O 0.5 g; FeCl3 (1%) 0.5 mL; glucose 5 g; malt extract 5.0 g; aqua 
purificata 1000 mL, pH 7.5) were inoculated with a homogenized pre-culture of a mycelial culture of 
the strain 222 and cultivated on a rotary shaker (125 rpm) for 19 days at room temperature. 
3.3. Extraction and Isolation 
Mycelium and fermentation broth were separated and the culture broth was extracted with EtOAc. 
The organic layer was dried with anhydrous sodium sulfate and then concentrated in vacuum using a 
rotary evaporator to  give a brown residue (500 mg from 11 L of culture broth). The extract  was 
fractionated by CC (system 1) to yield seven fractions (A–G) according to chemical monitoring by Mar. Drugs 2011, 9                     
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TLC. Fraction D (70 mg) was further subjected to CC (system 2) and 8 fractions (D1–D8) were 
separated through TLC guided fractionation. Fraction D4 was further purified by RP-HPLC to yield 
6.5 mg of balticolid (1). 
3.4. Balticolid (1) 
Colorless oil, [α]
22
D + 135.2 (c = 0.35, MeOH); TLC EtOAc:DCM (3:1) Rf = 0.3 (yellow spot after 
spraying  with  anisaldehyde/H2SO4  reagent  and  heating);  HPLC  UV  detection  at  216  nm,  
Rt = 12.2 min.; UV in MeOH λmax (log ε) 214 (5456/3.736); IR (KBr) υmax 3435, 1715, 1662, 1170, 
980 cm
−1; HPLC-ESI-MS (ammonium acetate buffer): +ESI m/z 225 [M + H]
+, 242 [M + NH4]
+, 247 
[M + Na]
+ and 470 [2M + Na]
+; −ESI m/z 223 [M − H]
−. HR-(+)-ESI-MS: 471.2001, calcd. 471.1995 
for C24H32O8Na as [2M + Na]
+. 
3.5. Preparation of (S)- and (R)-MTPA Esters of Balticolid (1) 
Two  portions  (1.5  mg  each)  of  1  were  dissolved  in  dry  CH2Cl2  (1  mL)  containing  1  mg  of 
dimethylaminopyridine and eight equivalents of dicyclohexylcarbodiimide. Six equivalents of either 
the (S) or the (R) isomer of α-methoxy-α-trifluoromethylphenylacetyl chloride were added to a portion 
of 1. The reaction mixtures were allowed to stand for 24 h at room temperature. The reaction was 
quenched by addition of 1.0 mL of water, and the mixture was subsequently extracted with Et2O  
(3 ×  1.0 mL). The Et2O soluble layers were combined, dried over anhydrous MgSO4 and evaporated. 
The residue was subjected to column chromatography over silica gel using n-hexane-EtOAc (13:1) to 
yield the (S)-MTPA and (R)-MTPA esters. The key 
1H NMR chemical shift differences Δδ (δS − δR) in 
ppm for the MTPA esters of 1 are shown in Figure 3. 
3.6. Biological Activities 
An agar diffusion assay according to the European Pharmacopoeia [12] was used to determine 
antibacterial and antifungal activity. Ampicillin was used as positive control. The following test strains 
were used: Staphylococcus aureus ATCC 6538, Escherichia coli ATCC 11229, and Candida maltosa 
SBUG 700. The compound was tested for antiviral activity  against influenza A virus and  Herpes 
simplex  virus  (HSV)  type  I  using  a  test  system  as  described  by  Shushni  et  al.  [4].  Briefly,  the  
virus-host systems influenza A virus—Madine-darby canine kidney (MDCK) cells and Herpes simplex 
virus—African green monkey kidney (Vero) cells were used. Confluent monolayers of the cells were 
pre-incubated treated with different concentrations of balticolid or reference compounds amantadine 
and acyclovir in four replicates for 30 min at 37 ° C. MDCK cells were infected with 30 TCID50 (tissue 
culture infectious dose leading to virus infection of 50% of the cells) of influenza virus A and Vero 
cells with 30 TCID50 of HSV-I and further incubated for 72 h at 37 ° C. The antiviral effect of test 
compounds was determined by neutral red assay in comparison to infected cells without test compound 
and non infected cells. Before antiviral tests a possible cytotoxicity of balticolid for MDCK and Vero 
cells was measured also by the neutral red assay. Only non-cytotoxic concentrations were used for the 
antiviral tests. 
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